Characteristic | OPC | OCC | P | OPC | OCC | P | P’ | P” |
---|---|---|---|---|---|---|---|---|
Men | Women | |||||||
Mean age at tumour diagnosis | 60.5 ± 10.9 | 63.6 ± 13.2 | <0.001* | 63.5 ± 12.3 | 67.1 ± 14.8 | <0.001* | <0.001* | <0.001* |
Age | ||||||||
<50 years | 287 (19.0%) | 413 (15.3%) | <0.001* | 76 (13.9%) | 213 (13.1%) | <0.001* | <0.001* | <0.001* |
51-60 years | 492 (32.5%) | 633 (23.5%) | 159 (29.1%) | 294 (18.1%) | ||||
61-70 years | 447 (29.6%) | 782 (29.0%) | 138 (25.2%) | 406 (25.0%) | ||||
71 years & above | 286 (18.9%) | 864 (32.1%) | 174 (31.8%) | 714 (43.9%) | ||||
Year of tumour diagnosis | ||||||||
1981-85 | 99 (6.5%) | 416 (15.5%) | <0.001* | 55 (10.1%) | 217 (13.3%) | 0.008* | 0.004* | <0.001* |
1986-90 | 160 (10.6%) | 481 (17.9%) | 71 (13.0%) | 229 (14.1%) | ||||
1991-95 | 201 (13.3%) | 491 (18.2%) | 84 (15.4%) | 287 (17.6%) | ||||
1996-2000 | 245 (16.2%) | 471 (17.5%) | 88 (16.1%) | 301 (18.5%) | ||||
2001-05 | 393 (26.0%) | 446 (16.6%) | 137 (25.0%) | 310 (19.1%) | ||||
2006-10 | 414 (27.4%) | 387 (14.4%) | 112 (20.5%) | 283 (17.4%) | ||||
Ethnicity | ||||||||
South Asian | 42 (2.8%) | 97 (3.6%) | 0.37 | 20 (3.7%) | 77 (4.7%) | 0.02* | 0.04* | 0.001* |
Chinese | 51 (3.4%) | 85 (3.2%) | 10 (1.8%) | 83 (5.1%) | ||||
General population | 1419 (93.8%) | 2510 (93.2%) | 517 (94.5%) | 1467 (90.2%) | ||||
Stage at diagnosis | ||||||||
Early | 211 (14.0%) | 907 (33.7%) | 124 (22.7%) | 615 (37.8%) | <0.001* | <0.001* | <0.001* | |
Late | 1245 (82.3%) | 1138 (42.3%) | 392 (71.7%) | 598 (36.8%) | ||||
Unknown | 56 (3.7%) | 647 (24.0%) | 31 (5.7%) | 414 (25.4%) |